Exelon Patch 9mg, manufactured by Novartis Pharma, contains rivastigmine, an acetylcholinesterase inhibitor. It is used for the treatment of mild to moderate dementia associated with Alzheimer’s disease or Parkinson’s disease, delivered as a 9mg transdermal patch. (YJ code: 1190700S2025, Standard: 9mg x 1).
Exelon Patch 9mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).